Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
暂无分享,去创建一个
C. Rudin | S. Gadgeel | R. Gedrich | M. Middleton | R. Juergens | S. Gogov | V. Macaulay | S. Eckhardt | S. Poondru | A. Stephens | S. McCarthy